Use of interfering rna for treating an hiv infection

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9127279
APP PUB NO 20120095082A1
SERIAL NO

13378754

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to interfering RNAs, in particular miRNAs, capable of specifically blocking the replication of a strain of the HIV virus that is resistant to an antiretroviral compound, and use thereof for treating infections by this type of virus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS3 AVENUE VICTORIA PARIS 75004
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)4 PLACE JUSSIEU PARIS 75005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Calvez, Vincent Paris, FR 10 17
Marcelin, Anne-Geneviève Paris, FR 6 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00